Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-10 · accession 0001193125-25-316351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-11 | 2025-12-10 | LMAT | LeBlanc Dorian Paul | CFO | A - Grant | $0.00 | +1,177 | 2,398 | +96% | $0 |
| D | 2025-12-11 | 2025-12-10 | LMAT | LeBlanc Dorian Paul | CFO | A - Grant | $0.00 | +7,222 | 7,222 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-10 | A | A | 1,177 | $0.00 | 2,398 | D | — | — | (F1) Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-12-10 | A | A | 7,222 | $0.00 | 7,222 | D | $83.66 · 2025-12-01 to 2032-12-10 | 7,222 Common Stock | (F2) This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. |